Epigenomic Modulators and Thyroid Hormone Receptor β Agonists: A New Paradigm for Tumor Suppression in Thyroid Cancer.

Saved in:
Bibliographic Details
Title: Epigenomic Modulators and Thyroid Hormone Receptor β Agonists: A New Paradigm for Tumor Suppression in Thyroid Cancer.
Authors: Rustad JL; University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Gillis NE; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Lignos J; University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Bright KA; University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Department of Biomedical Health Sciences, College of Nursing and Health Sciences, University of Vermont, Burlington, VT 05405, USA., Frietze S; University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Department of Biomedical Health Sciences, College of Nursing and Health Sciences, University of Vermont, Burlington, VT 05405, USA., Carr FE; University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Source: Endocrinology [Endocrinology] 2025 Jul 08; Vol. 166 (9).
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited Medium: Internet ISSN: 1945-7170 (Electronic) Linking ISSN: 00137227 NLM ISO Abbreviation: Endocrinology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1945-7170
DOI:10.1210/endocr/bqaf116